ArticleScientific reports2025
Comparative analysis of RAD-seq methods for SNP discovery and genetic diversity assessment in oil seed crop safflower.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Safflower (Carthamus tinctorius L.) is an important oilseed crop with diverse uses and the potential for genetic improvement. This study aimed to optimize genotyping-by-sequencing (GBS) for safflower via in silico and in vitro methods with two restriction site-associated DNA sequencing (RAD-seq) approaches, i.e., single restriction site-associated DNA sequencing (sdRAD-seq) and double-digest RAD sequencing (ddRAD-seq) and three restriction enzyme combinations (ApeKI, NlaIII_Msel, and EcoRI_Msel). Forty-two safflower accessions were selected for this study. In silico testing revealed that NlaIII_Msel generated the largest number of DNA fragments, followed by ApeKI and EcoRI_Msel. The in vitro results showed that ddRAD-seq outperformed sdRAD-seq in terms of raw read count, alignment rate, depth and breadth of coverage, and SNP detection. An alignment-free analysis using k-mer counting and sketching based on genetic distance further confirmed the superiority of ddRAD-seq. Gene-level k-mer validation identified more core genes in the ddRAD-seq data. Variant calling resulted in 6,721, 173,212, and 221,805 single nucleotide polymorphic sites (SNPs) for ApeKI, NlaIII_Msel, and EcoRI_Msel, respectively. SNP annotation and distribution analysis revealed that EcoRI_Msel captured more SNPs with fewer missing observations. Principal component analysis via ddRAD-seq data explained 30.29% and 33.98% of the total genetic variation in NlaIII_Msel and EcoRI_Msel, respectively. This study demonstrated that ddRAD-seq with the EcoRI_Msel enzyme combination is the most suitable GBS approach for genome sampling and SNP genotyping in safflower.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.